$GENC Cashflow Statement | Understand Stock

$GENC

$17.15 -$0.07 (0.41%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Purchase of marketable securities
Proceeds from sale and maturity of marketable securities
Change in value of marketable securities
Unrealized gain on marketable securities
Deferred income taxes
Unrecognized tax benefits
Depreciation and amortization
Provision for credit losses
Loss on disposal of assets
Changes in operating assets and liabilities:
Accounts receivable
Costs and estimated earnings in excess of billings
Contract assets
Marketable securities
Inventories
Prepaid expenses
Accounts payable
Customer deposits
Accrued expenses
Accrued expenses and other

Total adjustments
Net cash provided by operating activities
Cash flows from investing activities:
Acquisition of Blaw-Knox assets
Capital expenditures
Cash used in investing activities

Proceeds from stock option exercises
Cash flows provided by financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at:
Beginning of year
End of year
Non-cash investing and financing activities:
Operating lease right-of-use assets
Operating lease liabilities
Right-of-use assets obtained in exchange for operating lease liabilities

Comments